- Home
- MYND vs BOLD Comparison
MYND vs BOLD Comparison
Compare MYND & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- BOLD
- Stock Information
- Founded
- MYND 1998
- BOLD 2018
- Country
- MYND United States
- BOLD United States
- Employees
- MYND N/A
- BOLD N/A
- Industry
- MYND Other Consumer Services
- BOLD
- Sector
- MYND Real Estate
- BOLD
- Exchange
- MYND Nasdaq
- BOLD Nasdaq
- Market Cap
- MYND 27.6M
- BOLD 24.4M
- IPO Year
- MYND 2017
- BOLD 2024
- Fundamental
- Price
- MYND $0.59
- BOLD $1.12
- Analyst Decision
- MYND
- BOLD Buy
- Analyst Count
- MYND 0
- BOLD 4
- Target Price
- MYND N/A
- BOLD $4.00
- AVG Volume (30 Days)
- MYND 68.7K
- BOLD 72.2K
- Earning Date
- MYND 08-27-2025
- BOLD 08-05-2025
- Dividend Yield
- MYND N/A
- BOLD N/A
- EPS Growth
- MYND N/A
- BOLD N/A
- EPS
- MYND N/A
- BOLD N/A
- Revenue
- MYND $209,800,000.00
- BOLD N/A
- Revenue This Year
- MYND N/A
- BOLD N/A
- Revenue Next Year
- MYND N/A
- BOLD N/A
- P/E Ratio
- MYND N/A
- BOLD N/A
- Revenue Growth
- MYND N/A
- BOLD N/A
- 52 Week Low
- MYND $0.53
- BOLD $1.00
- 52 Week High
- MYND $3.89
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- MYND 40.37
- BOLD 47.83
- Support Level
- MYND $0.56
- BOLD $1.11
- Resistance Level
- MYND $0.72
- BOLD $1.19
- Average True Range (ATR)
- MYND 0.05
- BOLD 0.05
- MACD
- MYND 0.01
- BOLD -0.00
- Stochastic Oscillator
- MYND 30.53
- BOLD 64.29
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.